Apogee Therapeutics Inc’s recently made public that its Chief Executive Officer HENDERSON MICHAEL THOMAS unloaded Company’s shares for reported $0.73 million on Jan 08 ’25. In the deal valued at $48.85 per share,15,000 shares were sold. As a result of this transaction, HENDERSON MICHAEL THOMAS now holds 1,309,487 shares worth roughly $53.75 million.
Then, HENDERSON MICHAEL THOMAS bought 15,000 shares, generating $732,675 in total proceeds.
Before that, Dambkowski Carl sold 4,085 shares. Apogee Therapeutics Inc shares valued at $191,740 were divested by the Chief Medical Officer at a price of $46.94 per share. As a result of the transaction, Dambkowski Carl now holds 255,348 shares, worth roughly $10.48 million.
Canaccord Genuity initiated its Apogee Therapeutics Inc [APGE] rating to a Buy in a research note published on November 25, 2024; the price target was $89. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. BTIG Research began covering APGE with “Buy” recommendation on December 20, 2023. Wedbush started covering the stock on August 08, 2023. It rated APGE as “an Outperform”.
Price Performance Review of APGE
On Friday, Apogee Therapeutics Inc [NASDAQ:APGE] saw its stock fall -16.58% to $41.05. Over the last five days, the stock has lost -12.94%. Apogee Therapeutics Inc shares have fallen nearly -9.38% since the year began. Nevertheless, the stocks have risen 33.50% over the past one year. While a 52-week high of $72.29 was reached on 01/07/25, a 52-week low of $29.06 was recorded on 01/10/25. SMA at 50 days reached $49.04, while 200 days put it at $49.36.
Levels Of Support And Resistance For APGE Stock
The 24-hour chart illustrates a support level at 37.30, which if violated will result in even more drops to 33.55. On the upside, there is a resistance level at 46.57. A further resistance level may holdings at 52.09. The Relative Strength Index (RSI) on the 14-day chart is 36.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.77%. Stochastics %K at 60.08% indicates the stock is a holding.
How much short interest is there in Apogee Therapeutics Inc?
A steep rise in short interest was recorded in Apogee Therapeutics Inc stocks on 2024-12-13, growing by 1.35 million shares to a total of 7.97 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 6.62 million shares. There was a rise of 16.93%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 08, 2023 when TD Cowen began covering the stock and recommended ‘”an Outperform”‘ rating .
